Objective:To study the bioequivalence of domestic and imported glipizide tablets.
目的：研究国产格列吡嗪片剂的生物等效性。
The top 3 hypoglycemic drugs in respect of sales amount were acarbose, gliclazide, and glipizide.
用药金额排名前3位的药物是阿卡波糖、格列齐特、格列吡嗪。
AIM: To provide a method for study of glipizide pharmacokinetics and development of it's products.
目的：为研究格列吡嗪的药物动力学及其制剂的开发提供方法。
Objective: To study the clinical effects of pioglitazone combined with glipizide on type 2 diabetes therapy.
目的：观察吡格列酮联用格列齐特缓释片治疗2型糖尿病的临床疗效。
Glimepiride, glipizide, glyburide and repaglinide lead to too-low blood sugar more often than other drugs do.
与其他药物相比，格列美脲、格列吡嗪、格列本脲和瑞格列奈更容易导致低血糖。
Objective To study the relative bioavailability and bioequivalence of compound glipizide in healthy volunteers.
目的研究复方格列吡嗪片人体生物利用度及生物等效性。
Objective To study the effect of glipizide-XL on endothelium-dependent relaxing function in type 2 diabetic patients.
目的探讨格列吡嗪控释片对2型糖尿病患者血管内皮功能的影响。
CONCLUSION: There were no differences in pharmacokinetic parameters between the domestic and the imported glipizide tablets.
结论：国产和进口格列吡嗪片的药代动力学参数无差异。
Objective To observe the effect and side effect of Glipizide XL combined with Acarbose on patients with type 2 diabetes mellitus(T2DM).
目的观察瑞易宁和拜唐苹联合治疗初发2型糖尿病的疗效及安全性。
CONCLUSION the method is an accurate for the drug release determination of Glipizide Sustained release Capsules, the analysis is out of interference of excipients.
结论方法结果准确，不受制剂中辅料的干扰，适用于格列吡嗪缓释胶囊的释放度测定。
The weight ratio of glipizide to metformin hydrochloride is 1 : 100-200, the best ratio is 1:100 and it adds a proper amount of medicinal auxiliary to the preparation.
缓释制剂中格列吡嗪和盐酸二甲双胍的重量比范围1∶100至1∶200，最优比例为1∶100，制剂中加入适量药用辅料。
Methods The content of dimethydiguanide was determined by ultraviolet spectrophotometry, and the content of glipizide was determined by high-performance liquid chromatography(HPLC).
方法用紫外分光光度法测定该制剂中盐酸二甲双胍的含量，高效液相色谱法测定格列吡嗪的含量。
Conclusions The glipizide film-controlled sustained-release pellets were successfully prepared and the in-vitro drug release conformed to the requirements of the sustained-release formulation.
结论成功制备了膜控型格列吡嗪缓释微丸，体外释放符合缓释制剂要求。
Conclusions The glipizide film-controlled sustained-release pellets were successfully prepared and the in-vitro drug release conformed to the requirements of the sustained-release formulation.
结论成功制备了膜控型格列吡嗪缓释微丸，体外释放符合缓释制剂要求。
应用推荐